F16.9

Clinical Causes: Experimentation with psychoactive substances for recreational or spiritual purposes Use of street drugs such as LSD, psilocybin (magic mushrooms), mescaline, or DMT without proper documentation Seeking altered states of consciousness or mind-expanding experiences Cultural or traditional practices involving hallucinogenic substances Potential self-medication for mental health issues, though generally not advised

Key Symptoms: Altered perceptions of reality, such as visual or auditory hallucinations Distorted sense of time and space Euphoria or an altered mood state Confusion or disorientation Anxiety, paranoia, or panic attacks Nausea or gastrointestinal discomfort Dilated pupils Rapid or irregular heart rate Impaired judgment and coordination Potential for psychotic episodes in some individuals

Diagnosis Path: Diagnosis of hallucinogen use, unspecified (F16.9), typically involves a comprehensive assessment by a healthcare professional, including a detailed medical history and physical examination. Due to the nature of this diagnosis being unspecified, additional investigative tests—such as toxicology screens—may be performed to detect hallucinogenic substances. Clinicians evaluate signs and symptoms presented and consider possible underlying mental health conditions. Since the specific substance isn't identified, further inquiry into the patient's substance use history or testing is crucial. This diagnosis indicates recent use but lacks detailed classification of the type or amount of hallucinogen involved.

Treatment Protocols: Emergency intervention in cases of acute psychological distress or dangerous behavior Psychological support and counseling to address underlying issues related to substance use Detoxification protocols if physical dependence is suspected, under supervised medical care Therapy focused on abstinence, relapse prevention, and harm reduction Referral to specialized addiction treatment programs or mental health services Monitoring for long-term psychological effects such as persistent hallucinations or psychosis Education about the risks associated with hallucinogen use